Hysteroscopic Intrauterine Suturing
Launched by HAEMEK MEDICAL CENTER, ISRAEL · Oct 23, 2024
Trial Information
Current as of August 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method called hysteroscopic intrauterine suturing, which involves using a special tool (the Apollos X-tack) to place stitches inside the uterus. The main goal is to see if this technique is safe and effective for women who are having a laparoscopic hysterectomy, which is a surgery to remove the uterus. Researchers will check if the stitches remain in place after the surgery and will also monitor for any complications during the procedure.
Women aged 65 to 74 who need a hysterectomy for non-cancerous reasons may be eligible to participate in this study. However, those with any signs of cancer will not be included. Participants in this trial can expect to have their safety and the procedure's effectiveness monitored closely. It's important to note that the trial is not yet recruiting participants, so interested individuals will need to wait until the study begins.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Benign indication for hysterectomy
- Exclusion Criteria:
- • Evidence or suspicious for malignancy
About Haemek Medical Center, Israel
Haemek Medical Center, located in Israel, is a leading healthcare institution renowned for its commitment to advancing medical research and patient care. With a strong emphasis on clinical trials, the center collaborates with multidisciplinary teams to explore innovative treatments and therapies across various medical fields. Haemek Medical Center is dedicated to maintaining high ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing valuable insights to the global medical community. Through its robust research programs and state-of-the-art facilities, the center aims to enhance healthcare outcomes and foster scientific advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Afula, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported